EP 1003524 A1 20000531 - NEW FORMULATION
Title (en)
NEW FORMULATION
Title (de)
NEUE FORMULIERUNG
Title (fr)
NOUVELLE FORMULATION
Publication
Application
Priority
- SE 9800455 W 19980313
- SE 9700934 A 19970314
Abstract (en)
[origin: US6197341B1] The invention provides a unit formulation which comprises a 2-hydroxy-5-phenylazobenzoic acid derivative which is particularly sodium balsalazide dihydrate which formulation has a density of at least 0.9 mg/mm3 and its use in the treatment of gastrointestinal diseases.
IPC 1-7
IPC 8 full level
A61K 9/20 (2006.01); A61K 31/655 (2006.01); A61P 1/00 (2006.01); A61P 1/04 (2006.01); A61P 35/00 (2006.01)
CPC (source: EP US)
A61K 9/2027 (2013.01 - EP US); A61K 9/2095 (2013.01 - EP US); A61K 31/655 (2013.01 - EP US); A61P 1/00 (2017.12 - EP); A61P 1/04 (2017.12 - EP); A61P 35/00 (2017.12 - EP)
Citation (search report)
See references of WO 9841212A1
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
US 6197341 B1 20010306; AU 6430198 A 19981012; BE 1011837 A5 20000201; BR 9808140 A 20000328; CA 2283297 A1 19980924; EP 1003524 A1 20000531; FR 2760638 A1 19980918; GR 980100096 A 19981130; HU P0000850 A2 20000928; HU P0000850 A3 20001030; JP 2001519782 A 20011023; NL 1008575 A1 19980915; NL 1008575 C2 19990910; NO 994431 D0 19990913; NO 994431 L 19990913; PL 335700 A1 20000508; SE 9700934 D0 19970314; WO 9841212 A1 19980924
DOCDB simple family (application)
US 6882398 A 19980514; AU 6430198 A 19980313; BE 9800201 A 19980313; BR 9808140 A 19980313; CA 2283297 A 19980313; EP 98909944 A 19980313; FR 9803077 A 19980312; GR 980100096 A 19980306; HU P0000850 A 19980313; JP 54042198 A 19980313; NL 1008575 A 19980312; NO 994431 A 19990913; PL 33570098 A 19980313; SE 9700934 A 19970314; SE 9800455 W 19980313